Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.89 |
| ▸ | THRB | P10828 | 1/20 | 0.89 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecane SCHEMBL27534862 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Fluoride SCHEMBL27634219 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Tetradecane SCHEMBL28298788 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Dodecane SCHEMBL28640565 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Fluoride SCHEMBL28664164 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Heptane SCHEMBL30107 | 1.00 | — | — | |
| Decane SCHEMBL25391362 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Dodecane SCHEMBL29078900 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Octane SCHEMBL28508043 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 | |
| Nonane SCHEMBL27653117 | 1.00 | TSHR (0.89) | TSHRTHRBLMNADNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3162801-B1 | SALT OF HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | UBE INDUSTRIES (JP) | 2020-07-22 | — | — | EP | disclosed |
| CN-110114441-A | Composition, film, laminate structure, light emitting device and display | 住友化学株式会社 | 2019-08-09 | — | — | CN | disclosed |
| US-10023554-B2 | Halogen-substituted heterocyclic compound salt | UBE INDUSTRIES, LTD. (JP) | 2018-07-17 | — | — | US | disclosed |
| CN-107835835-A | Fluorinated thermosets with iodine end groups | 3M创新有限公司 | 2018-03-23 | — | — | CN | disclosed |
| US-20170158663-A1 | HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND SALT | UBE INDUSTRIES, LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| EP-3162801-A1 | SALT OF HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | UBE Industries, Ltd. (JP) | 2017-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158663-A1 | HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND SALT | LPAR1, LPAR3, LPAR2 | TSHR 84/4885THRB 361/4885LMNA 2758/4885 |
| US-10023554-B2 | Halogen-substituted heterocyclic compound salt | LPAR1, LPAR2, LPAR3 | TSHR 87/4885THRB 348/4885LMNA 2792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.